FREE Account Opening + No Clearing Fees
Loading...

Brooks Laboratories Ltd IPO Message Board (Page 11)

Loading...
13. firdous fatima |   Link |  Bookmark | August 14, 2011 5:19:43 AM
SBI Q1 net down 46% at Rs 1,583 cr on rise in provisions

sbi results will make lot of difference - next week

nifty target 49oo
12. YESH |   Link |  Bookmark | August 13, 2011 4:16:47 PM
@ Manoj goyal,
What is harm if someone publish the information which are helpful to others. You cannot ask anybody what and what not to publish.
It is his personal and He can publish wrong or right information it is you to judge the information.
This is a public forum. Only restriction is abuse and other non-parliamentary words.
11. manoj goyal |   Link |  Bookmark | August 13, 2011 7:28:49 AM
I request to all readers please donot send information about comission or brokerage slab becouse this information is personal not public Information. This type of massage also commercial massage witch is against this site rules also this is way from brokers to marketing their business so be awaire all sender brokers are mis guide we. Please consider your agent service and sugession not comission
10. Sampath |   Link |  Bookmark | August 12, 2011 5:49:46 PM
Hi experts Could you please tell me is this good IPO? Can we go for this for listing gains?

Advance thanks :)
9. jackpot |   Link |  Bookmark | August 11, 2011 10:42:19 PM
shriram bond--2.5 times approx
8. jackpot |   Link |  Bookmark | August 11, 2011 10:09:01 PM
kostak-2600.00
7. Grey Kostak |   Link |  Bookmark | August 11, 2011 8:26:06 PM
Brooks - 2 Lacs - 2400/-
6. Dash |   Link |  Bookmark | August 11, 2011 4:58:06 PM
Hi Expart,

is it good to invest in Brooks Lab , atleast for gain in Listing..
5. RAM JAIPUR WALE |   Link |  Bookmark | August 11, 2011 2:07:41 PM
jo is ipo me lagayega usko apni capital ka 30% vapas milega.
4. tejas j shah |   Link |  Bookmark | August 11, 2011 10:45:09 AM
The financial are as under:

PAT: 688.82 million

EPS: 4.25 (Post Issue)

P/E Ratio: 23.49 times

Brooks Laboratories is a pharmaceutical company with focus on CRAMS segment.As far as valuation are concerned, issue has been priced @ 23 times to 2011 earnings which is on expensive side & providing no room for appreciation. but as small issue can see firework on listing but that also limited to intraday trading
3. Rkg |   Link |  Bookmark | August 10, 2011 3:10:10 PM
Top Contributor Top Contributor (500+ Posts, 200+ Likes)
Financials for 4 years not given at this site.
2. kandavelu s |   Link |  Bookmark | August 9, 2011 7:48:45 AM
one more issue at high price
1. A LA |   Link |  Bookmark | August 9, 2011 1:05:16 AM
Seems to be high priced.